Erythromycin D (EP) ; 3”-O-demethyl-12-deoxy Erythromycin
(3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-[(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12-dihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione (as per EP)
HSN Code :
Country of Origin :
Status :
Mol. Wt :
Synonyms :
Chemical Name :
38229010
India
Synthesis on demand
703.9
Erythromycin D (EP) ; 3”-O-demethyl-12-deoxy Erythromycin
(3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-[(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12-dihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione (as per EP)
+917744015207
info@medglowpharma.com | sales@medglowpharma.com
H.N. 1-1-111,Swapnaganda, Paras Nagar ,Nanded Maharastra, India -431602
Monday to Saturday 9am to 7pm
Services
API intermidates
Custom synthesis
API impurities
Working standards
Portfolio
Medglow Pharma Private Limited is a newly incorporated private company, registered under the Registrar of Companies (RoC), RoC-Delhi. It was registered with an authorized and paid-up capital of ₹1,00,000. The company falls under the class of Non-government companies. It was registered in 2025.
